Glenmark Specialty S.a.

Glenmark Pharmaceuticals S.a.

Suresh Rajurkar

Ulhas R Dhuppad

Sunil Chaudhari

Chandrakant Dhatrak

Franciscus Koppenhagen

Alkesh Kasliwal

Nilesh Jayantilal Jain

Nilesh Jain

The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.

Tiotropium inhalation solution for nebulization

The present invention relates to a nanoparticulate formulation comprising a transient receptor potential ankyrin-1 receptor ('TRPA1') antagonist. Particularly, the present invention relates to a nanoparticulate formulation comprising a thienopyrimidinedione derivative as a TRPA1 antagonist and a surface stabilizer; a process for preparing such formulation; and its use in treating a respiratory disorder or pain in a subject.

Nanoparticulate formulation comprising a TRPA1 antagonist

Growing community of inventors

Nashik, India

Suresh Rajurkar